60-kDa热休克蛋白调控能量重排与蛋白合成促进多发性骨髓瘤细胞增殖
该研究采用液相色谱-串联质谱对多发性骨髓瘤(MM)患者与健康对照的CD138+浆细胞进行蛋白质组学分析,发现HSP60在骨髓瘤细胞中显著上调。HSP60敲低可抑制骨髓瘤细胞增殖、降低线粒体质量,并抑制糖酵解、线粒体活性及磷酸戊糖途径相关合成。结果表明HSP60参与MM代谢重编程,是潜在治疗靶点。
要点
- HSP60在MM患者CD138+浆细胞中显著上调。
- HSP60敲低抑制骨髓瘤细胞增殖并降低线粒体质量。
- HSP60敲低抑制糖酵解、线粒体活性及磷酸戊糖途径合成。
核心结论
- HSP60表达降低可改变MM代谢重编程,抑制肿瘤进展并减少线粒体依赖性生物合成,提示HSP60是MM潜在治疗靶点。
研究设计与样本
- 采用液相色谱-串联质谱对MM患者与健康对照的CD138+浆细胞进行蛋白质组学分析,并在骨髓瘤细胞中进行HSP60敲低实验。
主要发现
- HSP60在骨髓瘤细胞中显著上调。
- HSP60敲低导致骨髓瘤细胞增殖抑制和线粒体质量下降。
- 线粒体应激测试显示HSP60敲低抑制糖酵解和线粒体活性。
- 代谢组学显示糖酵解和三羧酸循环代谢物减少,TFB1M介导的SAM与氨基酸反应生成的肌酸和磷酸肌酸形成受抑,能量储存物质减少。
- HSP60沉默影响磷酸戊糖途径合成核糖核苷酸和NADPH,抑制细胞增殖;HSP60敲低抑制AMPK,进而抑制PFKFB3,并通过抑制丙二酰辅酶A影响脂肪酸代谢。
临床怎么用
- HSP60可作为MM代谢重编程的潜在治疗靶点,但需进一步临床验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
To investigate the cellular mechanisms of multiple myeloma (MM), we used liquid chromatography-tandem mass spectrometry for proteomics analysis of CD138+ plasma cells from patients with MM and healthy controls. We found that the 60-kDa heat shock protein (HSP60, also known as HSPD1) was significantly upregulated in myeloma cells. HSP60 is an important chaperone protein that regulates the homeostasis of mitochondrial proteins and maintains mitochondrial function. Knockdown (KD) of HSP60 in myeloma cells resulted in inhibition of proliferation and reduced the quality of the mitochondria. Mitochondrial stress tests showed that HSP60 KD inhibited glycolysis and mitochondrial activity. Metabolomics showed a decrease in glycolysis and tricarboxylic acid cycle metabolites, and inhibited the formation of creatine and phosphocreatine by the reaction of S-adenosylmethionine (SAM) with amino acids mediated by demethyladenosine transferase 1, mitochondrial (TFB1M) and reduced energy storage substances. Moreover, HSP60 silencing influenced the synthesis of ribonucleotides and nicotinamide adenine dinucleotide phosphate (NADPH) by the pentose phosphate pathway to inhibit cell proliferation. HSP60 KD inhibited 5' adenosine monophosphate-activated protein kinase (AMPK), which inhibited the key enzyme 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFKFB3), effecting the metabolism of fatty acids by inhibiting malonyl-coenzyme A. Our data suggest that reduced HSP60 expression alters metabolic reprogramming in MM, inhibits tumour progression and reduces mitochondrial-dependent biosynthesis, suggesting that HSP60 is a potential therapeutic target for MM treatment.
引用
- Wu X, Guo J, Chen Y, et al. The 60-kDa heat shock protein regulates energy rearrangement and protein synthesis to promote proliferation of multiple myeloma cells. Br J Haematol. 2020. PMID: 32155663. doi:10.1111/bjh.16569
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。